Literature DB >> 14629110

Microarray analysis of hepatic gene expression in gallstone-susceptible and gallstone-resistant mice.

Patricia A Dyck1, Farzana Hoda, Elizabeth S Osmer, Richard M Green.   

Abstract

Cholesterol gallstone disease affects 40 million Americans, and evidence indicates that there is a genetic component to human gallstone disease. In a mouse model of gallstone formation, where mice are fed a lithogenic diet, QTL analysis has been employed to identify the Lith 1 locus on Chromosome (Chr) 2. In order to identify genes in which the difference in expression is independent of factors other than strain-specific genotype, we employed microarray analysis of hepatic gene expression in gallstone-susceptible (C57L/J) and gallstone-resistant (AKR/J) mice. We observed 57 genes with consistent differential expression between C57L/J and AKR/J mice, including many cytochrome, antioxidant, and lipid peroxidation genes. Analysis of differentially expressed genes identified numerous genes involved in fatty acid metabolism. Northern analysis of selected lipid metabolic genes further confirmed the strain-specific differential expression. Literature searches of common regulatory elements within antioxidant systems identified the nuclear transcription factor Nrf2, which maps to the Lith 1 loci. Hepatic Nrf2 gene and protein expression is also increased in strain AKR/J, compared with C57L/J mice, identifying Nrf2 as a putative Lith 1 gallstone gene. These data indicate that microarray analysis may complement QTL analysis to identify systems of regulation and genotypic differences responsible for polygenic diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629110     DOI: 10.1007/s00335-003-2269-9

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  34 in total

1.  HDL receptor SR-BI and cholesterol gallstones.

Authors:  Attilio Rigotti; Silvana Zanlungo; Juan Francisco Miquel; David Q-H Wang
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

2.  Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a "foreign body".

Authors:  M A Pappolla; R A Omar; Y J Chyan; J Ghiso; K Hsiao; P Bozner; G Perry; M A Smith; F Cruz-Sanchez
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

3.  Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis.

Authors:  A F Attili; R Capocaccia; N Carulli; D Festi; E Roda; L Barbara; L Capocaccia; A Menotti; L Okolicsanyi; G Ricci; L Lalloni; S Mariotti; C Sama; E Scafato
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

4.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

5.  Reactive oxygen metabolites promote cholesterol crystal formation in model bile: role of lipid peroxidation.

Authors:  M I Eder; J F Miquel; D Jongst; G Paumgartner; C von Ritter
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  A pilot study of antioxidant intake in patients with cholesterol gallstones.

Authors:  H V Worthington; L P Hunt; R F McCloy; I Maclennan; J M Braganza
Journal:  Nutrition       Date:  1997-02       Impact factor: 4.008

Review 7.  Pathogenesis and treatment of gallstones.

Authors:  D E Johnston; M M Kaplan
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

8.  Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.

Authors:  M Fuchs; B Ivandic; O Müller; C Schalla; J Scheibner; P Bartsch; E F Stange
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

9.  Serum ascorbic acid and other correlates of gallbladder disease among US adults.

Authors:  J A Simon; E S Hudes
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

10.  Mitochondrial disease in superoxide dismutase 2 mutant mice.

Authors:  S Melov; P Coskun; M Patel; R Tuinstra; B Cottrell; A S Jun; T H Zastawny; M Dizdaroglu; S I Goodman; T T Huang; H Miziorko; C J Epstein; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

View more
  1 in total

1.  Serious limitations of the QTL/microarray approach for QTL gene discovery.

Authors:  Ricardo A Verdugo; Charles R Farber; Craig H Warden; Juan F Medrano
Journal:  BMC Biol       Date:  2010-07-12       Impact factor: 7.431

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.